Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Inventory (2016 - 2025)

IGC Pharma (IGC) has disclosed Change in Inventory for 16 consecutive years, with -$6000.0 as the latest value for Q3 2025.

  • Quarterly Change in Inventory changed N/A to -$6000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$167000.0 through Sep 2025, up 83.68% year-over-year, with the annual reading at -$180000.0 for FY2025, 82.14% up from the prior year.
  • Change in Inventory for Q3 2025 was -$6000.0 at IGC Pharma, up from -$11000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $322000.0 in Q1 2021, with the low at -$1.9 million in Q1 2022.
  • Average Change in Inventory over 5 years is -$206111.1, with a median of -$8000.0 recorded in 2023.
  • Peak annual rise in Change in Inventory hit 3800.0% in 2022, while the deepest fall reached 683.54% in 2022.
  • Over 5 years, Change in Inventory stood at -$71000.0 in 2021, then soared by 97.18% to -$2000.0 in 2022, then surged by 1250.0% to $23000.0 in 2023, then tumbled by 434.78% to -$77000.0 in 2024, then surged by 92.21% to -$6000.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$6000.0, -$11000.0, and -$73000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.